Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Brain Metastases
Related studies linked through entity extraction aliases.
Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Detection and Metabolic Characterization in DOPA PET/CT of Brain Metastases
- Status
- COMPLETED
- Phase
- NA
Dose-staged Gamma Knife Radiosurgery Versus Microsurgical Resection
- Status
- RECRUITING
- Phase
- NA
Evaluation of Neratinib for Treatment and Prevention of Subsequent CNS Event(s) in Patients With Brain Metastasis of Advanced HER2 Positive Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Intraoperative Radiotherapy in Patients With Brain Metastases
- Status
- RECRUITING
- Phase
- NA
ASL in Brain Metastasis MRI Following Gamma Knife Treatment
- Status
- RECRUITING
- Phase
- NA
Keynatinib in Treated Patients With NSCLC and Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
A Dose Exploration Study of Almonertinib for EGFRm NSCLC Patients With Brain/Leptomeningeal Metastasis (ARTISTRY)
- Status
- UNKNOWN
- Phase
- NA
TKIs vs. Pertuzumab in HER2+ Breast Cancer Patients With Active Brain Metastases (HER2BRAIN)
- Status
- UNKNOWN
- Phase
- PHASE2
SGM-101 in Colorectal Brain Metastases.
- Status
- RECRUITING
- Phase
- PHASE2
Genomic Study in Non-small Cell Lung Cancer Brain Metastasis
- Status
- COMPLETED
- Phase
- N/A
Use of Non-invasive Optical Analysis in Neurosurgery
- Status
- UNKNOWN
- Phase
- NA
Diffusion-weighted MRI to Predict Treatment Response in Stereotactic Radiotherapy of Central Nervous System (CNS) Metastases
- Status
- UNKNOWN
- Phase
- NA
Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery
- Status
- RECRUITING
- Phase
- PHASE1
Central Nervous System(CNS) Efficacy of Dacomitinib
- Status
- UNKNOWN
- Phase
- PHASE2
Metachronic Brain Metastases After Esophagectomy for Esophageal Cancer (METABREC)
- Status
- RECRUITING
- Phase
- N/A
SRS Timing With Immune Checkpoint Inhibition in Patients With Untreated Brain Metastases From Non-small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Phase II Trial of Upfront Radiotherapy Plus Almonertinib for Epidermal Growth Factor Receptor(EGFR)-Mutant Non-small-cell Lung Cancer(NSCLC) Patients With Brain Metastases
- Status
- UNKNOWN
- Phase
- PHASE2